FXYD6-FXYD2: A Drug Target / Disease Biomarker (G100533181)

Target Name: FXYD6-FXYD2

NCBI ID: G100533181

FXYD6-FXYD2: A Drug Target / Disease Biomarker

FXYD6-FXYD2 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the family of transmembrane proteins, which means that it spans the cell membrane and extends into the space between cells. This protein is of particular interest because it has been shown to play a role in a variety of biological processes, including cell signaling, neurodegeneration, and disease.

One of the most promising aspects of FXYD6-FXYD2 is its potential as a drug target. FXYD6 has been shown to interact with a variety of molecules, including G protein-coupled receptors (GPCRs), which are a family of membrane receptors that play important roles in cellular signaling. GPCRs are a common target for drug development because they are relatively easy to target and can be modulated with small molecules.

FXYD6 has also been shown to interact with the protein p120伪, which is a modification of the protein p120 that is involved in the detoxification of drugs. p120伪 has been shown to play a role in drug resistance, and may be a useful target for the development of drug-resistant diseases.

In addition to its potential as a drug target, FXYD6-FXYD2 is also of interest as a biomarker for a variety of diseases. For example, FXYD6 has been shown to be involved in neurodegeneration, and may be a useful biomarker for conditions such as Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in cancer, and may be a useful biomarker for the development and progression of cancer.

Overall, FXYD6-FXYD2 is a protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in biology and to develop effective treatments.

Protein Name: FXYD6-FXYD2 Readthrough

More Common Targets